VeinWay Closes Oversubscribed SAFE Round and Begins Series A Round
Vascular Surgeons Stephen Black, MD, and Houman Jalaie, MD, PhD join VeinWay’s Scientific Advisory Board. OR YEHUDA, Israel, Sept. 7, 2023 /PRNewswire/ — VeinWay has closed an oversubscribed SAFE round of investment and has opened a series A round. The... Read More →
Velentium Listed on Inc 5000 for Fourth Consecutive Year
Velentium, a professional engineering firm that specializes in the design and manufacturing of therapeutic and diagnostic active medical devices, announces it was once again recognized as one of the fastest-growing private companies in America. Inc. ranked Velentium No. 2725 on... Read More →
Admetsys’ FDA Breakthrough Designation Accelerates Arrival of Fully Autonomous Clinical Robotics in Hospital
BOSTON, Sept. 6, 2023 /PRNewswire/ — Admetsys Corporation, a biomedical technology company specializing in critical care automation, announced today that the FDA has designated its automated glucose control and continuous blood diagnostics system a Breakthrough Device. This designation accelerates the... Read More →
Vitestro starts largest-scale clinical trial globally for its autonomous blood drawing device, with enrolment of first patients in A.D.O.P.T.
UTRECHT, The Netherlands, Sept. 6, 2023 /PRNewswire/ — Vitestro, expert in medical robotics, has launched the A.D.O.P.T. Trial for its autonomous blood drawing device (image). With an anticipated sample size of over 10,000 patients, this is the most significant study... Read More →
Abbott to Acquire Bigfoot Biomedical, Furthering Efforts to Develop Personalized, Connected Solutions for People with Diabetes
Bigfoot developed Bigfoot Unity, a smart insulin management system that features the first and only FDA-cleared connected insulin pen caps that turn data from a continuous glucose monitor (CGM) into clear and reliable insulin dosing recommendations displayed right on the... Read More →
CardieX Sets U.S. IPO at 1.33 Million ADSs Priced at $7.50-$8 Each
Australian medical-device maker CardieX on Wednesday said it plans to sell more than 1.33 million American depositary shares at between $7.50 and $8 apiece in its U.S. initial public offering. Read More
PolyVascular, CobiCure partner on non-surgical pediatric heart valve
CobiCure Medical Technologies announced that it provided $2 million in funding to PolyVascular to advance a pediatric heart valve. Houston-based PolyVascular — a MedTech Innovator accelerator participant in 2020 — develops a first-of-its-kind heart valve. The potentially transformative, non-surgical valve... Read More →
TechCruch selects CellChorus for Startup Battlefield 200 at TechCrunch Disrupt
Fewer than 50 health and bio companies selected to present at TechCrunch event in San Francisco from September 19th to 21st HOUSTON, Texas — August 24, 2023 — CellChorus Inc. today announced that TechCrunch has selected CellChorus to present at... Read More →
Sparta Biomedical Celebrates Prestigious Recognition in MedTech and Significant Milestone
MORRISVILLE, N.C., Aug. 24, 2023 /PRNewswire/ — Sparta Biomedical Inc, a pioneering medical technology company specializing in redefining osteoarthritis treatment, proudly reflects on a momentous period marked by significant recognition and notable achievements. Sparta’s inclusion among the top 61 MedTech... Read More →
SG healthtech startup Neurowyzr secures additional $2.1m in Peak XV-led round
Neurowyzr, a Singapore-based health tech startup, has raised an additional $2.1 million in funding from Peak XV Partners, formerly known as Sequoia Capital India and SEA, and other investors, according to its filings with Singapore’s Accounting and Corporate Regulatory Authority... Read More →